PRKCQ and neoplasm: AlphaScreen of a compound library identifies NSC617570 as an efficient inhibitor of PRKCQ‐AS1 RNA and MSI2 protein interaction, and NSC617570 reduces BMX expression, ERK protein phosphorylation, neuroblastoma cell proliferation in vitro and tumor progression in mice.